FY2025 Earnings Estimate for Danaher Issued By William Blair

Danaher Corporation (NYSE:DHR) – Analysts at William Blair dropped their FY2025 earnings per share estimates for Danaher in a research note issued to investors on Wednesday, October 22nd. William Blair analyst M. Larew now anticipates that the conglomerate will post earnings of $7.71 per share for the year, down from their previous estimate of $7.72. The consensus estimate for Danaher’s current full-year earnings is $7.63 per share. William Blair also issued estimates for Danaher’s Q4 2025 earnings at $2.14 EPS, Q1 2026 earnings at $2.00 EPS, Q2 2026 earnings at $1.97 EPS, Q3 2026 earnings at $1.99 EPS, Q4 2026 earnings at $2.38 EPS and FY2026 earnings at $8.35 EPS.

A number of other research firms have also commented on DHR. Cowen reaffirmed a “buy” rating on shares of Danaher in a research report on Wednesday. TD Cowen raised their price target on Danaher from $250.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday. Rothschild & Co Redburn reaffirmed a “neutral” rating and issued a $220.00 price target (down previously from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Evercore ISI raised their price target on Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 7th. Finally, Bank of America decreased their price objective on shares of Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a report on Monday, September 22nd. Eighteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $243.39.

Danaher Stock Performance

Shares of NYSE:DHR opened at $223.03 on Friday. The company has a 50-day moving average price of $202.73 and a 200-day moving average price of $198.36. The company has a market cap of $157.54 billion, a price-to-earnings ratio of 45.99, a price-to-earnings-growth ratio of 3.41 and a beta of 0.77. The company has a current ratio of 1.52, a quick ratio of 1.22 and a debt-to-equity ratio of 0.33. Danaher has a 12 month low of $171.00 and a 12 month high of $258.23.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Citizens Financial Group Inc. RI increased its stake in shares of Danaher by 5.1% in the 3rd quarter. Citizens Financial Group Inc. RI now owns 21,160 shares of the conglomerate’s stock worth $4,195,000 after acquiring an additional 1,025 shares in the last quarter. Alley Investment Management Company LLC increased its stake in shares of Danaher by 0.5% during the third quarter. Alley Investment Management Company LLC now owns 44,268 shares of the conglomerate’s stock valued at $8,777,000 after purchasing an additional 227 shares in the last quarter. Tema Etfs LLC increased its stake in shares of Danaher by 211.4% during the third quarter. Tema Etfs LLC now owns 16,256 shares of the conglomerate’s stock valued at $3,223,000 after purchasing an additional 11,035 shares in the last quarter. Philip James Wealth Mangement LLC bought a new position in shares of Danaher during the third quarter valued at approximately $387,000. Finally, Sachetta LLC increased its position in Danaher by 3.2% during the 3rd quarter. Sachetta LLC now owns 2,183 shares of the conglomerate’s stock valued at $433,000 after buying an additional 68 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 11.10% of the company’s stock.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio is 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.